Akcea Therapeutics (AKCA) Stock: Tanking On FDA Rejection
Akcea Therapeutics Inc (NASDAQ: AKCA) is having an overwhelmingly rough start to the trading session this morning after the company announced that the FDA rejected a treatment it was hoping to get approved in partnership with Ionis Pharmaceuticals Inc (NASDAQ: IONS). Of course, the rejection upset investors, sending the stock tumbling down. Today, we’ll talk about: … Read more